Candel Therapeutics Files 8-K
Ticker: CADL · Form: 8-K · Filed: May 22, 2025 · CIK: 1841387
| Field | Detail |
|---|---|
| Company | Candel Therapeutics, INC. (CADL) |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
Related Tickers: CADL
TL;DR
Candel Therapeutics filed a routine 8-K, no major news.
AI Summary
Candel Therapeutics, Inc. filed an 8-K on May 22, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Candel Therapeutics is adhering to its reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting purposes and does not disclose any new material risks or events.
Key Players & Entities
- Candel Therapeutics, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of Report
- 001-40629 (other) — Commission File Number
- 52-2214851 (other) — IRS Employer Identification No.
- Needham, Massachusetts (location) — Principal Executive Offices
FAQ
What is the purpose of this 8-K filing for Candel Therapeutics, Inc.?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is May 22, 2025.
What is Candel Therapeutics, Inc.'s Commission File Number?
Candel Therapeutics, Inc.'s Commission File Number is 001-40629.
Where are Candel Therapeutics, Inc.'s principal executive offices located?
Candel Therapeutics, Inc.'s principal executive offices are located at 117 Kendrick St Suite 450, Needham, Massachusetts, 02494.
Does this filing indicate any changes to Candel Therapeutics, Inc.'s name or address since the last report?
The filing lists 'Not Applicable' for Former Name or Former Address, if Changed Since Last Report, suggesting no changes were reported in this section.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding Candel Therapeutics, Inc. (CADL).